Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer: A Pooled Analysis of Individual Participant Data From 3 Prospective Studies

医学 合并分析 结直肠癌 内科学 腺癌 前瞻性队列研究 化疗 肿瘤科 完全响应 荟萃分析 癌症
作者
Jianwei Zhang,Xiaoyu Xie,Zehua Wu,Huabin Hu,Yue Cai,Jianxia Li,Jiayu Ling,Miaomiao Ding,Weiwei Li,Yanhong Deng
出处
期刊:Clinical Colorectal Cancer [Elsevier BV]
卷期号:20 (4): e240-e248 被引量:19
标识
DOI:10.1016/j.clcc.2021.06.004
摘要

To evaluate the predictive implications and prognosis of mucinous adenocarcinoma (MAC) in locally advanced rectal cancer (LARC) with intensified neoadjuvant treatment.Individual patient data of LARC patients from 3 prospective clinical trials was analyzed. Neoadjuvant treatment regimens comprised chemoradiotherapy (CRT) with fluorouracil (5-FU) or mFOLFOX6, neoadjuvant chemotherapy alone with mFOLFOX6 or mFOLFOXIRI. The postoperative pathological result, local recurrence and disease-free survival (DFS) were retrospectively analyzed in patients with MAC and adenocarcinoma (AC) with neoadjuvant treatment.Totally, 743 patients were recruited, with 620 patients eligible for analysis. Fifty-three (8.5%) patients were MAC. The pathological complete response (pCR) rate and tumor downstaging rate (ypStage 0-I) between MAC and AC patients was 7.5% vs. 22.0% (P = .01) and 20.8% vs. 48.7% (P < .001), respectively. Among patients receiving preoperative CRT with 5FU or mFOLFOX6, the pCR rate and tumor downstaging rate between MAC and AC patients was 11.1% vs. 27.3% (P = .03) and 23.7% vs. 52.6% (P = .001), respectively. Regarding neoadjuvant chemotherapy alone with mFOLFOX6 or mFOLFOXIRI, the pCR rate and tumor downstaging rate was 0 vs.13.2% (P = .11) and 11.8% vs. 42.5% (P = .03) between MAC and AC group, respectively. With the median follow-up time of 38.9 months, the 3-year DFS and 3-year locoregional recurrence rate was 58.4% vs. 77.6% (P = .02) and 26.0% vs. 5.7% (P = .001) in the MAC and AC group, respectively. MAC (hazard ratio [HR] 1.85, 95% confidence interval [CI], 1.15-2.98), PNI (HR 3.23, 95% CI, 1.85-5.72) and LVI (HR 2.04, 95% CI, 1.02-4.08) were independent prognosis factors and were associated with worse DFS.Patients with MAC of the rectum are associated with a lower pCR rate and tumor downstaging rate, higher incidence of local recurrence, and poorer DFS with neoadjuvant treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
善良的非笑完成签到,获得积分10
3秒前
3秒前
小二郎应助jiabaoyu采纳,获得10
3秒前
无奈秋荷发布了新的文献求助10
4秒前
5秒前
黄哈哈发布了新的文献求助10
6秒前
多多发布了新的文献求助10
6秒前
8秒前
李健的小迷弟应助Brian采纳,获得10
8秒前
8秒前
8秒前
liujian完成签到,获得积分10
9秒前
9秒前
脑洞疼应助wl301采纳,获得20
10秒前
10秒前
早安发布了新的文献求助10
10秒前
顾矜应助小岚花采纳,获得10
10秒前
11秒前
12秒前
12秒前
242588发布了新的文献求助10
12秒前
深情安青应助感性的梦竹采纳,获得10
13秒前
jiabaoyu发布了新的文献求助10
15秒前
Lc应助谷大喵唔采纳,获得10
15秒前
ff发布了新的文献求助10
16秒前
16秒前
16秒前
16秒前
Zarc完成签到,获得积分10
17秒前
无奈秋荷完成签到,获得积分10
18秒前
元谷雪发布了新的文献求助10
18秒前
20秒前
拼搏的酸奶完成签到,获得积分10
21秒前
Brian发布了新的文献求助10
21秒前
22秒前
22秒前
咖啡蓝图发布了新的文献求助10
22秒前
22秒前
24秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988827
求助须知:如何正确求助?哪些是违规求助? 3531197
关于积分的说明 11252739
捐赠科研通 3269830
什么是DOI,文献DOI怎么找? 1804815
邀请新用户注册赠送积分活动 881915
科研通“疑难数据库(出版商)”最低求助积分说明 809028